Dana-Farber Cancer Institute has received a $50 million donation from the Pan-Mass Challenge.
Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center received a one-year, $135,000 grant from the Connecticut Lions Eye Research Foundation to fund uveal melanoma research.
Friends of Cancer Research has launched a collaboration that aims to address concerns about the lack of consistency in determining homologous recombination deficiency—HRD—status, its prognostic value, and its use as a predictive biomarker.
Jack. T. Evjy, Chang Oh Turkmani and Elizabeth M. Fago were appointed to the National Cancer Advisory Board Dec. 8.
GRAIL and United Kingdom's National Health Service are collaborating to make GRAIL's multi-cancer early detection blood test, Galleri, available to UK patients starting in 2021.
Raymond Bergan was named deputy director of the Fred & Pamela Buffett Cancer Center at University of Nebraska Medical Center.
E. Ramsay Camp was named professor and chief of surgical oncology in the Michael E. DeBakey Department of Surgery's Division of Surgical Oncology at Baylor College of Medicine.
Harikrishna Nakshatri, a researcher at Indiana University Melvin and Bren Simon Comprehensive Cancer Center, received a $1.3 million grant from the Department of Defense to characterize unique biomarkers within the normal breasts of Black women and how that impacts health disparities in breast cancer.
The American Association for Cancer Research and FDA will collaborate on the Project Livin' Label, an educational initiative that aims to foster broad understanding of specific oncology product labels and increase awareness of recent oncology drug FDA approvals.
The Ohio State University Comprehensive Cancer Center – Arthur G. James and Richard J. Solove Research Institute has established a center dedicated to maintaining and expanding the legacy of the late Clara D. Bloomfield. The center will be initially supported by a $5 million commitment from the OSUCCC – James.
